ISIS Clinica Especializada
About ISIS Clinica Especializada
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Helsinn Healthcare SA
2
Agennix
1
Bristol-Myers Squibb
1
CTI BioPharma
1
Clovis Oncology, Inc.
1
Daiichi Sankyo, Inc.
1
Genentech, Inc.
1
Heidelberg Pharma AG
1
Institut de Recherches Internationales Servier
1
Mast Therapeutics, Inc.
1
Clinical Trials at ISIS Clinica Especializada
During the past decade, ISIS Clinica Especializada conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
2003-09-01
2007-03-01
Completed
Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
2004-07-01
2012-10-01
Completed
864
BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
2004-07-01
2010-07-01
Completed
140
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
2004-09-01
2009-10-01
Completed
1,783
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ISIS Clinica Especializada" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Helsinn Healthcare SA" with 2 trials
sponsored, "Agennix" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "CTI BioPharma"
with 1 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ISIS Clinica Especializada"
#1 collaborator was "Parexel" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator and "Eurofarma Laboratorios S.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at ISIS Clinica Especializada
According to Clinical.Site data, the most researched conditions in "ISIS Clinica Especializada" are
"Breast Cancer" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Melanoma" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "ISIS Clinica Especializada" in a lesser frequency.
Clinical Trials Intervention Types at ISIS Clinica Especializada
Most popular intervention types in "ISIS Clinica Especializada" are "Drug" (22 trials), "Biological" (4 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Erlotinib" (3 trials), "Paclitaxel" (3 trials), "Trastuzumab" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at ISIS Clinica Especializada
The vast majority of trials in "ISIS Clinica Especializada" are
18 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at ISIS Clinica Especializada
Currently, there are NaN active trials in "ISIS Clinica Especializada".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in ISIS Clinica Especializada,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ISIS Clinica Especializada, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of ISIS Clinica Especializada
ISIS Clinica Especializada has several departments that took part in Clinical trials: "Centro Modelo de Cardiologia" - 5 trials, "Instituto de Asistencia Reumatologica Integral" - 4 trials
Departments List
Name
City
Trials